PharmaGossipAtLast

  • Subscribe to our RSS feed.
  • Twitter
  • StumbleUpon
  • Reddit
  • Facebook
  • Digg

Monday, July 15, 2013

First GSK denied......

Posted on 2:56 PM by Unknown

GSK Admits China Corruption Claims 'Shameful'

By Mark Stone, Asia Correspondent

Chinese police have released further details of what they claim is a massive programme of bribery by GlaxoSmithKline (GSK) in China.

According to a police official in Beijing, the British drugs manufacturer has transferred as much as £323m to over 700 travel consultants since 2007.

Separately, TV interviews have emerged with some of the GSK staff alleged to have been involved in the bribery.

The Chinese authorities allege that GSK officials used the travel agents as vehicles through which to bribe doctors, hospital bosses and government officials. According to Chinese police, the travel agents were paid to offer services to officials in return for the purchase of GSK branded products.

Gao Feng, the head of the Economic Crime Investigation Unit of China's ministry of public security, claimed that some travel agents offered "sexual bribery" to GSK employees to secure favours. He did not elaborate on those allegations.

In a statement to Sky News, GSK said: "We are deeply concerned and disappointed by these serious allegations of fraudulent behaviour and ethical misconduct by certain individuals at the company and third-party agencies. Such behaviour would be a clear breach of GSK's systems, governance procedures, values and standards. GSK has zero tolerance for any behaviour of this nature. 

"In the meantime, we are taking a number of immediate actions. We are reviewing all third party agency relationships. We have put an immediate stop on the use of travel agencies that have been identified so far in this investigation and we are conducting a thorough review of all historic transactions related to travel agency use.

"GSK fully respects the laws and regulations in China and expects all staff to abide by them. GSK shares the desire of the Chinese authorities to root out corruption. These allegations are shameful and we regret this has occurred. We will cooperate fully with the Chinese authorities in the investigation of these new allegations.

Signage is pictured on the company headquarters of GlaxoSmithKline in west London
The GSK global headquarters in Brentford, west London

"We will take all necessary action required by the outcome of this investigation," the statement concluded.

According to police, four senior Chinese executives from the firm are being held and questioned.

China's Xinhua State News Agency named them as: Vice President and Operations Manager Liang Hong, Vice President and Human Resources Director Zhang Guowei, Legal Affairs Director Zhao Hongyan, and Business Development Manager Huang Hong.

In TV interviews aired by China's state-run CCTV (China Central Television), the suspects are heard apparently confessing to the bribery.

Speaking in Chinese, one of the employees, Liang Hong said: "We began to cooperate with Shanghai Linjiang International Travel Service Co Ltd since 2010.

"Within the following three years, about 10 meetings had been held, with participants ranging from over 100 in small meetings to 2,000 in large-scale meetings."

A reporter then asks him how much money would be involved in one of the large scale meetings.

"The expenses for the largest-scale one exceeded ten million yuan (£1.07m)." Liang says.

In another interview, an employee from one of the travel firms reportedly used by GSK staff, explains the alleged process.

"He (Liang Hong) said he need to visit a professional or a leader and bring some gifts with him," Weng Jianyong, Boss of Shanghai Linjiang International Travel Agency said.

"But according to the company (GSK) discipline, the gift can only value 100 or 200 yuan, (£10-£20) so it doesn't work at all. Then he said to me to give him some cash.

"The money sometimes reaches 500,000 yuan (£50,000) for an activity," Weng Jianyong alleged.

Last week, Sky sources confirmed that a British national was detained and questioned by Chinese authorities in Shanghai last week. He or she has since been released.

Sources revealed that dozens of Chinese police entered the GSK Shanghai offices on June 27, went into the offices of senior British staff and seized paperwork.

After the raid GSK circulated an internal memo, seen by Sky News, which said: "At this stage, it is unclear about the precise nature/purpose of their visit and investigation.

"We will of course cooperate with their inquiries, but are unable to comment further at this stage."

GSK operates a zero-tolerance policy toward bribery and issues staff with a 16-page booklet outlining its guidelines.

The Brentford-based company said in June that it had already investigated an accusation that its sales people in China bribed doctors and found no evidence of wrongdoing.

The drug-giant has a growing business in China. It currently employs more than 5,000 people at eight sites across the country and has investments totalling £300m.

  • Related Stories
  • GSK Denies China Corruption Claims
  • GlaxoSmithKline Returns To Profit
  • Huge US Healthcare Fraud Payout By GSK
http://news.sky.com/story/1115993/gsk-admits-china-corruption-claims-shameful
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted in | No comments
Newer Post Older Post Home

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Posts

  • Beautiful Barcelona! - Gedeon Richter ruled in breach of ABPI code
    LYNNE TAYLOR Gedeon Richter (UK) has breached the Association of the British Pharmaceutical Industry (ABPI) Code of Practice, and has brough...
  • GlaxoChinaGate contd. - Bwaaa!
    China Drug Probe 'Unfair,' Euro Group Says Thu, 09/05/2013 - 8:30am Foreign companies believe they are unfairly being singled out fo...
  • Another day, another J&J recall ... Mold found in schizophrenia drug forces Johnson & Johnson recall
    By  Bloomberg News  on September 11, 2013 at 5:25 PM, updated  September 11, 2013 at 5:27 PM Johnson & Johnson has recalled 5,000 vials ...
  • AllTrials Update
    Dear Friends Support for AllTrials around the world is growing and we need to keep it that way as we reach some crucial debates. The Europea...
  • Hurrah!
    Press Release 11 September 2013 FOR IMMEDIATE RELEASE The HRA is now implementing its plans for ensuri...
  • Advertisement
    The book addresses, in great, evidence-based detail, a general system failure caused by widespread crime, corruption, bribery and impotent d...
  • Of pigs and penicillin
    Extended Withdrawal Needed to Avoid Penicillin G Residues News US - A minimum 51-day withdrawal is necessary if penicillin G is used in pigs...
  • The Lancet has formally retracted the Jikei Heart Study paper, originally published in 2007
    . The retraction had been widely anticipated for more than a month, after a series of news reports in Japan made it clear that the long-simm...
  • Wrigley holds off on caffeinated gum as FDA reviews caffeine
    By Melissa Healy 7:54 p.m. EDT, May 9, 2013 Less than a week after the Food and Drug Administration announced that it would investigate the ...
  • Petition by Professor David Healy - please sign if you agree
    Let us see Drug Data! Drug hazards are not “trade secrets”! Drug companies maximize the sales of new drugs by hyping their benefits while do...

Categories

  • Abbott (1)
  • alltrials (1)
  • alosetron (1)
  • AstraZeneca (1)
  • Baxter (1)
  • big pharma (2)
  • bribery (7)
  • Champix (1)
  • chantix (1)
  • china (7)
  • Clinical Trails (1)
  • Clinical Trial (1)
  • corruption (5)
  • Dan Markingson (1)
  • Dan Markingson Death (1)
  • diabetes (2)
  • Diovan (1)
  • EFPIA (1)
  • glaxo (11)
  • Glaxo China bribery corruption (1)
  • gsk (7)
  • hongbao (1)
  • insurance (1)
  • Januvia (1)
  • johnson and johnson (1)
  • Lotronex (1)
  • Mefloquine (1)
  • Mental Health (1)
  • Merck (2)
  • Novartis (1)
  • pancreas (1)
  • pfizer (1)
  • pharma (1)
  • pharmaceuticals (1)
  • PhRMA (1)
  • quetiapine (1)
  • Sanofi (2)
  • scandal (1)
  • seroquel (1)
  • side effects (1)
  • suvorexant (1)
  • ucb (1)
  • Valsartan (1)
  • Zaltrap (1)

Blog Archive

  • ▼  2013 (300)
    • ►  September (40)
    • ►  August (70)
    • ▼  July (104)
      • Still a fantastic read
      • GlaxoChinaGate contd. - Nothing uniquely Chinese a...
      • Hope for the future
      • Slumdog clinical trials contd. - BMJ editorial: In...
      • Let the sunshine in
      • Hongbao - the red envelope
      • Sharing data from clinical trials: where we are an...
      • Pfizer Pleads Guilty, Pays $491 Million Over Rapam...
      • Caveat lector!
      • Now this is worrying
      • FDA toughens malaria drug labeling because sometim...
      • An addiction that is hard to break
      • GlaxoChinaGate contd. The case of Zhao Hongyan, th...
      • Perrigo buys Irish drug maker Elan in $8.6bn deal
      • 1boringoldman makes the case for data transparency
      • GSK investigation reveals something rotten - China...
      • The Glaxo-China Bribery Scandal: A New Policeman W...
      • UK pharma shows signs of dangerous addiction
      • Paul Krugman: China’s economy has hit its Great Wall
      • Class-action suit over Pfizer Canada's anti-smokin...
      • GlaxoChinaGate contd. - Reilly to return to China!
      • China state media says 18 more detained in GSK probe
      • Bergstroem's mobilising memo
      • GlaxoChinaGate contd.- The World of Suzie Wang
      • GlaxoChinaGate contd. - is this the payoff?
      • Big Pharma’s data sharing principles “weak and fil...
      • GlaxoChinaGate contd. - the Chinese police reveal ...
      • Banks and Big Pharmas hire private eyes who break ...
      • Pharma industry downplays lobbyism with patient gr...
      • Meanwhile, in other GSK news...
      • GlaxoChinaGate contd. Witty may not be forthcoming...
      • The World According to Monsanto
      • Patient groups commit to transparency after leaked...
      • GSK's China crisis: questions for Witty that need ...
      • More Astra staff held in China as GSK crisis deepens
      • Antimalarial Drug Linked to Sgt. Robert Bales Mass...
      • Drug Research in China Falls Under a Cloud
      • How to lower Big Pharma's drug prices the Chinese way
      • It's a strange old world
      • A message from AllTrials.net
      • GSK's China Crisis spreads
      • Files Suggest a Graft Case in China May Expand - NYT
      • AllTrials contd. Which patient groups are in Big P...
      • Healthcare in China: GSK claims prompt crackdown o...
      • More on Peter Humphrey, MD of ChinaWhys
      • GSK boss to address China scandal at quarterly res...
      • Killing the chicken to scare the monkey
      • GlaxoSmithKline briefs Serious Fraud Office over C...
      • Comment: China crisis growing for troubled Glaxo
      • China - getting in is easier than getting out!
      • GlaxoSmithKline's China crisis: why it changes the...
      • GlaxoSmithKline rushes executives to China to hand...
      • GSK chief Andrew Witty set to admit China 'scam’
      • Can Merck Finally Get Past the Vioxx Scandal?
      • NHS could save £84m using cheaper drug to prevent ...
      • Worth every penny
      • China - Now UCB get a visit
      • Johnson and Johnson Settles Suit Alleging Manageme...
      • GSK China's General Manager Mark Reilly Presents O...
      • Pharma Companies Must End Secret Gifts To Doctors ...
      • Eli Lilly to Freeze Employee Base Pay Ahead of Gen...
      • Latest MTRAC reviews
      • China bars Glaxo finance director from leaving cou...
      • GSK's Andrew Witty's new role in China
      • Four Drugmakers Face China Probes as Glaxo Woes Widen
      • A fish starts to rot from the head. After GSK, who...
      • Sexual Favors Spur Glaxo’s $1.5 Billion China Sale...
      • First GSK denied......
      • GSK China - Watch the confession
      • Anyone know where GSK's Mark Reilly is?
      • AZ - Exit the gas man
      • Do Clinical Trials Work? - NYT
      • David Healy vs AbbVie - A good medicine is a chemi...
      • UK NHS hit for millions by overcharging ‘scam’ - ...
      • Chinese clinical trials probed
      • Did Big Pharma team up to kill British Columbia's ...
      • Japan vows action over claims of fabricated drug data
      • Stopping Big Pharma From Using New .pharmacy Domai...
      • Our medical schools must not become shills for big...
      • GSK vs PSB
      • China security ministry says GSK executives confes...
      • Merck 'Evergreens' Off-Patent Lipitor By Creating ...
      • Wolfe Attack!
      • Drug Rep$
      • Are Clinical Trial Data Shared Sufficiently Today?
      • Stop blanket animal antibiotics now - before it's ...
      • Castellani vs Goldacre
      • Recent €23 Million Biotech IPO Relied Heavily On Q...
      • Australia targets Nurofen
      • New bribery allegations hit GlaxoSmithKline in China:
      • GSK's Dierdre P. Connelly makes a promise
      • Gouging contd. - How to make a $300 drug cost $30,...
      • "It may have been Roaccutane"
      • Ghost- and Guest-Authored Pharmaceutical Industry-...
      • Drs. Oz & Roizen's Tip of the Day: What's up with ...
      • Tchotchke War Looms
      • Ten tips when writing about clinical trials by Rut...
      • Pfizer and Merck
      • An interesting case
      • Pharma "a prime target" of govt health cuts in 201...
      • Sanofi to cut 207 R&D jobs in latest French reshuffle
      • Clot Wars contd.
      • GlaxoSmithKline Probe in China Follows Drug Safety...
      • Merck's Mess
    • ►  June (81)
    • ►  May (5)
Powered by Blogger.